VIRP

VIRBAC

Stock Euronext / Paris – Stock Market Prices, News & Analysis

Virbac is dedicated to the development and production of veterinary medicines and vaccines for companion animals and livestock.

€ 373.00
1.45 %

VIRBAC

373.00
1.45 %
VIRP

Virbac is dedicated to the development and production of veterinary medicines and vaccines for companion animals and livestock.

Price history of VIRBAC
Price history of VIRBAC

Performance & Momentum

6 Months 5.73 %
1 Year 25.34 %
3 Years 26.56 %
5 Years 39.82 %

Strategic Analysis

VIRBAC • 2026

Virbac specializes in the development and production of veterinary drugs and vaccines, addressing a growing global market linked to animal health. Its positioning in the companion animal and livestock segments gives it notable product diversification and strong biotechnological expertise.

Strengths
  • International presence strengthening commercial resilience
  • Expertise in biotechnology applied to veterinary vaccines
  • Diversification between companion animals and farm animals
Weaknesses
  • Dependence on health regulations and veterinary standards
  • Sensitivity to fluctuations in agricultural and veterinary markets
Momentum

The sustained positive momentum over recent years reflects stable business momentum and growing investor confidence in the animal health sector. The lack of major recent news suggests a controlled operational trajectory with no visible disruptions.

Similar stocks to VIRBAC

Was this page helpful?

Your feedback helps us improve our research.

Take control
of your investments

Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.

  • Real-time multi-portfolio tracking
  • AI analysis of your positions
  • Counter your cognitive biases
Anantys Invest on iPhone